Evidence map›Paper›PMID 38478336›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2024

CD44-Based Detection of CSCs: CD44 Immunodetection by Flow Cytometry.

Lornella Seeneevassen, Anissa Zaafour, Christine Varon

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
2.3field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lornella Seeneevassen *INSERM U1312 BRIC Bordeaux Institute of Oncology, University of Bordeaux, Bordeaux, France.
Anissa Zaafour *INSERM U1312 BRIC Bordeaux Institute of Oncology, University of Bordeaux, Bordeaux, France.
Christine VaronINSERM U1312 BRIC Bordeaux Institute of Oncology, University of Bordeaux, Bordeaux, France. christine.varon@u-bordeaux.fr.
Université de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD44 has been described in many malignancies as a marker of cancer stem cells (CSCs). Several techniques can be used to detect these cells. Here we detail CD44 detection by flow cytometry, a precise technique allowing to determine the percentage of positive cells and the mean fluorescent intensity reflecting the CD44 expression by cells in the samples. The protocol explained here can be used to detect CD44 from cell suspensions prepared from tissues or in vitro cell cultures.

Indexed as

Hyaluronan ReceptorsNeoplastic Stem CellsFlow CytometryHyaluronan ReceptorsAntibodyCancerCancer stem cellCD44Flow cytometryImmunofluorescence

Identifiers

PMID38478336
OpenAlexW4392775606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.